Nov 03, 2025
96% profit increase after nine months – innoscripta SE delivers strong results
The article on stock3 analyses how innoscripta SE recorded a notable profit increase of approximately 96% for the first nine months. This performance underlines the company’s position in the Scale segment and highlights substantial operational progress.
Read more: https://stock3.com/news/innoscripta-96-gewinnplus-nach-neun-monaten-16760612
You Might Also Like
Mar 06, 2026
Global Expansion at innoscripta Leveraging R&D
Take advantage of tax credits and IP BOX in the United States and France with us!Innovative companies operate globally — and their R&D - tax strategy should be structured accordingly. The United States (IRC Section 41) and France (Crédit d’Impôt Recherche – CIR and IP BOX) represent some of the most established and scrutinized tax-based innovation regimes globally. Why International R&D - Tax Credits Are a Strategic LeverLiquidity Optimization:U.S. credits may offset federal income tax or payroll taxes for eligible startups; France’s CIR can reduce the corporate income tax liability and be refundable under qualifying conditions, France’s IP BOX provides for a reduced tax rate.Financial Reporting Impact:U.S. credits require ASC 740 analysis and uncertain tax position evaluation; French CIR and IP BOX affect refundable asset recognition and technical review exposure.Strategic Allocation:Multinationals can align R&D - footprint, IP ownership, and transfer pricing structures to optimize compliant credit outcomes.How U.S. and French Frameworks Strengthen Compliance Together The U.S. R&D - credit regime emphasizes the Four-Part Test, qualified research expense nexus, and contemporaneous substantiation standards. France’s CIR and IP BOX requires rigorous technical justification, scientific documentation, and structured project files. When harmonized correctly, these regimes reinforce internal controls:IRS focus on wage nexus and experimentation strengthens cost traceability.French CIR and IP BOX technical files reinforce scientific methodology documentation.OECD transfer pricing standards align global documentation expectations.Centralized documentation frameworks reduce duplication and mitigate multi-jurisdiction audit exposure.innoscripta’s Global Compliance Approach innoscripta provides a harmonized, technology-driven framework that connects technical activity, cost capture, and compliance workflows across jurisdictions. The platform supports structured documentation aligned with IRS substantiation standards, CIR and IP BOX technical requirements, and OECD principles — creating a defensible and repeatable R&D - governance model. Innovation knows no borders. A properly structured R&D - tax framework strengthens liquidity, governance, and audit defensibility across global operations.Think globally now – with a partner who is there for you locally:
Feb 13, 2026
DER AKTIONÄR interviews COO Sebastian Schwertlein on Clusterix and international expansion
DER AKTIONÄR features an interview with COO Sebastian Schwertlein on innoscripta’s development since the IPO, the technological positioning of the all-in-one platform Clusterix and the company’s expansion plans in Germany and across Europe. The discussion highlights platform differentiation, integrated R&D process tools and strategic growth priorities for the coming years.Know more: https://www.deraktionaer.de/artikel/aktien/innoscripta-coo-sebastian-schwertlein-ueber-den-boersengang-clusterix-und-expansionsplaene-20395466.html
